Browsing Tag: Lyrokaul

Key Highlights:  Implications:  Sun Pharma has signed an exclusive global licensing deal (ex‑US and ex‑China) with LIB Therapeutics for lerodalcibep, a once‑monthly PCSK9 inhibitor for lower...